Yunli Zhou
Tianjin, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Soluble Periostin is a potential surveillance biomarker for early and long-term response to chemotherapy in advanced breast cancer.
Journal: Cancer cell international
Published: September 03, 2023
Promoter methylation-mediated repression of UNC5 receptors and the associated clinical significance in human colorectal cancer.
Journal: Clinical epigenetics
Published: July 15, 2021
TGFβ regulates NK1R-Tr to affect the proliferation and apoptosis of breast cancer cells.
Journal: Life sciences
Published: February 14, 2020
miR-206 Promotes Cancer Progression by Targeting Full-Length Neurokinin-1 Receptor in Breast Cancer.
miR-206 Promotes Cancer Progression by Targeting Full-Length Neurokinin-1 Receptor in Breast Cancer.
Journal: Technology in cancer research & treatment
Published: September 12, 2019
UNC5D, suppressed by promoter hypermethylation, inhibits cell metastasis by activating death-associated protein kinase 1 in prostate cancer.
Journal: Cancer science
Published: November 02, 2018
MicroRNA-22 inhibits proliferation, invasion and metastasis of breast cancer cells through targeting truncated neurokinin-1 receptor and ERα.
Journal: Life sciences
Published: August 29, 2018
Identification of Serum Periostin as a Potential Diagnostic and Prognostic Marker for Colorectal Cancer.
Journal: Clinical laboratory
Published: June 27, 2018
MiR-34b/c-5p and the neurokinin-1 receptor regulate breast cancer cell proliferation and apoptosis.
Journal: Cell proliferation
Published: March 16, 2018
Lapatinib Inhibits Breast Cancer Cell Proliferation by Influencing PKM2 Expression.
Journal: Technology in cancer research & treatment
Published: January 19, 2018
Enzyme Kinetic Assay to Measure the Activity of Tumor M2 Pyruvate Kinase in Breast Cancer Patients.
Journal: Annals of clinical and laboratory science
Published: December 22, 2017
Last Updated: 09/26/2026